Latest Public Citizen Press Releases

For Immediate Release: 10/29/1998
FDA?s Approval of Tamoxifen to Reduce Incidence of Breast Cancer in Healthy Women Puts Women at Risk
Oct. 29, 1998 FDA?s Approval of Tamoxifen to Reduce Incidence of Breast Cancer in Healthy Women Puts Women at Risk ??? WASHINGTON, D.C. -- Public Citizen's Health Research Group finds it incredible that the Food and Drug Administration (FDA) has approved tamoxifen, a drug that is a known human carcinogen, to reduce the risk of breast cancer in women who are at a so-called high risk of the disease. Tamoxifen can induce tumors by altering a woman's DNA and may cause other types of cancers years later.
Complete Release >>

For Immediate Release: 10/29/1998
Big Tobacco Lobbying Costs $81,000 Per Member of Congress in First Half of 1998
Industry Blows Away Previous Record
Complete Release >>

For Immediate Release: 10/22/1998
New Report Shows California Consumers Deceived by "Green" Electricity Marketing Claims
Ratepayers Pay Extra Dollars for Sham Benefits
Complete Release >>

For Immediate Release: 10/13/1998
Campaign Cash at Work in Stealthy NAFTA Expansion: GOP Leaders Eye Omnibus Spending Bill
Oct. 13, 1998 Campaign Cash at Work in Stealthy NAFTA Expansion: GOP Leaders Eye Omnibus Spending Bill Clothing Industry Contributors Would Obtain Huge Benefits Lavish political contributions from two major apparel firms are fueling an attempt to slip a damaging trade deal through Congress in the final hours before adjournment.
Complete Release >>

For Immediate Release: 10/12/1998
New Legislation Lays Out Blueprint for Utility Deregulation; Requires Safeguards for Consumers and Environment
Consumer Advocates Applaud Bill Filed by Rep. Kucinich
Complete Release >>

For Immediate Release: 10/9/1998
Sneak Prescription Drug Patent Extension in Appropriations Rider Would Increase Drug Prices for Seniors
Oct. 9, 1998 Sneak Prescription Drug Patent Extension in Appropriations Rider Would Increase Drug Prices for Seniors WASHINGTON, D.C. -- An 11th-hour attempt to gain patent extensions for Claritin and Relafen, two of the top-selling prescription drugs in the U.S., and five other drugs would cost millions for consumers, taxpayers and all other health care payers. Among the hardest hit would be seniors on fee-for-service Medicare who pay out-of-pocket for outpatient prescription drugs.
Complete Release >>

For Immediate Release: 9/28/1998
Fast Track Buried in House Vote
Historic Victory Signals Shift in U.S. Politics and Policy on Trade and Globalization
Complete Release >>

For Immediate Release: 9/25/1998
"Prescription Drug Fairness for Seniors Act of 1998" Means Badly Needed Drug Price Relief for Medicare Beneficiaries
Sept. 25, 1998 "Prescription Drug Fairness for Seniors Act of 1998" Means Badly Needed Drug Price Relief for Medicare Beneficiaries Public Citizen strongly supports the "Prescription Drug Fairness for Seniors Act of 1998," legislation introduced today by Reps. Thomas Allen (D-Maine), Jim Turner (D-Texas), John Tierney (D-Mass.), Henry Waxman (D-Calif.) and 25 co-sponsors.
Complete Release >>

For Immediate Release: 9/18/1998
Health and Consumer Groups Slam Senate Bill 981's
Effect on Tobacco Control, Patients Rights and Food Safety
Complete Release >>

For Immediate Release: 9/15/1998
Regulators Cover Up Safety Problems During
Stock Offering of Government Corporatio
Complete Release >>

Pages